Research ArticleGINSENOSIDE RB2 (cas 11021-13-9) suppresses the glutamate-mediated oxidative stress and neuronal cell death in HT22 cells
-
Add time:08/16/2019 Source:sciencedirect.com
BackgroundThe objective of our study was to analyze the neuroprotective effects of ginsenoside derivatives Rb1, Rb2, Rc, Rd, Rg1, and Rg3 against glutamate-mediated neurotoxicity in HT22 hippocampal mouse neuron cells.
We also recommend Trading Suppliers and Manufacturers of GINSENOSIDE RB2 (cas 11021-13-9). Pls Click Website Link as below: cas 11021-13-9 suppliers
Prev:Research ArticleGinsenoside Rg3 (cas 11019-45-7) suppresses mast cell–mediated allergic inflammation via mitogen-activated protein kinase signaling pathway
Next:GINSENOSIDE RB2 (cas 11021-13-9) inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research ArticleTolerability and pharmacokinetics of ginsenosides Rb1, Rb2, Rc, Rd, and compound K after single or multiple administration of red ginseng extract in human beings08/22/2019
- Research ArticleGinsenoside Rb1 and Rb2 upregulate Akt/mTOR signaling–mediated muscular hypertrophy and myoblast differentiation08/21/2019
- Original articleGINSENOSIDE RB2 (cas 11021-13-9) inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway08/20/2019
- GINSENOSIDE RB2 (cas 11021-13-9) promotes glucose metabolism and attenuates fat accumulation via AKT-dependent mechanisms08/19/2019
- Research articleHighly regioselective biotransformation of GINSENOSIDE RB2 (cas 11021-13-9) into compound Y and compound K by β-glycosidase purified from Armillaria mellea mycelia08/18/2019
- GINSENOSIDE RB2 (cas 11021-13-9) inhibits epithelial-mesenchymal transition of colorectal cancer cells by suppressing TGF-β/Smad signaling08/17/2019
-
Health and Chemical more >